SCHEMBL20021074

SCHEMBL20021074

Cc1cc2nc(CN3CCCCC3)ccc2c(-c2ccc(Cl)cc2)c1CC(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
ALDH1A1 P00352 1/20 0.41
POLB P06746 1/20 0.41
HPGD P15428 1/20 0.41
MAPK1 P28482 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PTGDR2 Q9Y5Y4 3/20 0.41
MCHR1 Q99705 3/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
DHODH Q02127 2/20 0.38
FAAH O00519 1/20 0.38
FABP3 P05413 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
FABP4 P15090 1/20 0.38
FABP5 Q01469 1/20 0.38
AVPR1B P47901 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3323941 0.84 KDM4E (0.51) KDM4EMEN1KMT2AALDH1A1PTGDR2
SCHEMBL20020768 0.82 CNR1 (0.45) KDM4EALDH1A1POLBHPGDPTGDR2
SCHEMBL3297610 0.80 KDM4E (0.54) KDM4EMEN1KMT2AALDH1A1POLB
SCHEMBL20021110 0.80 KDM4E (0.45) KDM4EMEN1KMT2AALDH1A1PTGDR2
SCHEMBL20021165 0.79 KDM4E (0.52) KDM4EMEN1KMT2APTGDR2SMN1; SMN2
SCHEMBL3303954 0.79 KDM4E (0.53) KDM4EMEN1KMT2AALDH1A1HPGD
SCHEMBL243290 0.79 PSIP1 (0.47) KDM4EMEN1KMT2AALDH1A1POLB
SCHEMBL20021122 0.78 KDM4E (0.52) KDM4EMEN1KMT2AALDH1A1PTGDR2
SCHEMBL27910430 0.78 MEN1 (0.36) KDM4EMEN1KMT2AALDH1A1POLB
SCHEMBL3303958 0.77 KMT2A (0.49) KDM4EMEN1KMT2AALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2588455-B1 2-QUINOLINYL-ACETIC ACID DERIVATIVES AS HIV ANTIVIRAL COMPOUNDS GILEAD SCIENCES INC (US) 2018-04-04 EP disclosed